Hexarelin
GHRPHover to zoom

Qualified Research Reference

Hexarelin

Hexarelin is documented for controlled research models and literature-based evaluation only.

Lab TestedThird-party · Janoshik Analytical · ISO 17025View COA / Lab Report →
Formulation Strength
5mgper vial
Member Pricing
Regular
$99.99
Elite Member10%
$89.99
1
Research Description

Hexarelin is a synthetic hexapeptide GH secretagogue supplied as a lyophilized research peptide. Manufactured to a research-grade specification.

Studied in GH secretagogue receptor pharmacology, cardiovascular tissue signaling, and endocrine research models.

Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.

Research Profile

Hexarelin: investigational profile.

Research Mechanism

A synthetic hexapeptide GH secretagogue investigated for GHS-R and CD36 engagement, with a documented signaling profile in cardiac-tissue models alongside the pituitary axis.

Investigational Profile

In the GH secretagogue literature since the mid-1990s, frequently studied in parallel with GHRP-2 and GHRP-6 to compare potency across the series.

Research Study Window

Endocrine arms usually run two to six weeks; cardiac-signaling models often extend to eight weeks so tissue-level readouts have time to develop.

Formulation

Ingredients, disclosed.

Every compound and formulation strength documented without proprietary blends.

Compound
Dose
Research Context
Hexarelin
Per protocol
Synthetic hexapeptide GH secretagogue prepared for GHS-R and cardiac-signaling research.
Characteristics

Composition, documented.

Molecular Formula
C47H58N12O6
Molar Mass
887.03 g/mol
Amino Acid Sequence
H-His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2
Synonyms
Examorelin, GHRP-6 methylated analog
Solubility
Water-soluble
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder
FAQ

Questions, answered.